Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We present a protocol for utilizing a normothermic ex vivo sanguinous perfusion system for the delivery of therapeutics to an entire cardiac allograft in a porcine heterotopic heart transplant model.

Abstract

Cardiac transplantation is the gold standard treatment for end-stage heart failure. However, it remains limited by the number of available donor hearts and complications such as primary graft dysfunction and graft rejection. The recent clinical use of an ex vivo perfusion device in cardiac transplantation introduces a unique opportunity for treating cardiac allografts with therapeutic interventions to improve function and avoid deleterious recipient responses. Establishing a translational, large-animal model for therapeutic delivery to the entire allograft is essential for testing novel therapeutic approaches in cardiac transplantation. The porcine, heterotopic heart transplantation model in the intraabdominal position serves as an excellent model for assessing the effects of novel interventions and the immunopathology of graft rejection. This model additionally offers long-term survival for the pig, given that the graft is not required to maintain the recipient's circulation. The aim of this protocol is to provide a reproducible and robust approach for achieving ex vivo delivery of a therapeutic to the entire cardiac allograft prior to transplantation and provide technical details to perform a survival heterotopic transplant of the ex vivo perfused heart.

Introduction

Heart failure is a condition that affects an estimated 6 million adults in the United States and is projected to increase to 8 million adults by the year 20301. Cardiac transplantation is the gold standard treatment for end stage heart failure. However, it is not without its limitations and complications. It remains limited by the number of available donor hearts, primary graft dysfunction, rejection of the heart, and the side effects of long-term immunosuppression2. These limitations are particularly important in young recipients who may experience allograft failure and require subsequent re-transplantation to achieve n....

Protocol

NOTE: Two female Yucatan pigs are selected, with one designated to be the cardiac graft donor and the other the recipient. Pigs aged 6-8 months, weighing approximately 30 kg, and having compatible blood types are recommended. The overview of the protocol is demonstrated in Figure 1. Housing and the treatment procedures for the pigs are performed in accordance with the guidelines of the Animal Care and Use Committee of Duke University Medical Center.

1.

Representative Results

This group has successfully survived 9 pigs between 5 and 35 days following the protocol as presented here, depending on the study design. Out of 10 pigs that have undergone this protocol, only 1 died prematurely from surgical complications, yielding a 90% survival rate. Demonstrated in Figure 2 is a diagram of the configuration of a heterotopic heart transplanted in the intraabdominal position in a pig. When determining the site for anastomosis of the allograft, select a site that minimizes.......

Discussion

Delivery of therapeutics during ex vivo perfusion in cardiac transplantation offers a strategy to modify the allograft and potentially improve transplant outcomes. The protocol presented here incorporates the state-of-the-art normothermic ex vivo sanguinous perfusion storage and offers promising potential to test isolated delivery of cell, gene, or immunotherapies to the allograft11,12,13. To date, cardiac deli.......

Acknowledgements

We would like to thank Duke Large Animal Surgical Core and Duke Perfusion Services for their assistance during these procedures. We would also like to thank Paul Lezberg and TransMedics, Inc. for support.

....

Materials

NameCompanyCatalog NumberComments
0 Looped Maxon sutureCovidienGMM-341LUsed to close fascia of the laparotomy incision
0 Silk tiesMedtronic, IncS346
18 G AngiocathBD381144Used to de-air the left ventricle of the donor heart after implantation
20 Fr LV ventMedtronic, Inc12002
2-0 Silk suturesEthicon, Inc.SA11G
2-0 Silk tiesEthicon, Inc.SA65H
2-0 Vicryl sutureEthicon, Inc.J259H
24 Fr venous cannulaMedtronic, Inc68124
3-0 Prolene suturesEthicon, Inc.8522
4-0 Monocryl sutureEthicon, Inc.Y469G
4-0 Prolene suturesEthicon, Inc.8521
Animal hair cutting clipperWahl8786-452
Aortic clampV. MuellerCH6201
Army Navy retractorV. MuellerSU3660
ATF 40, Cell saver disposable setFresenius Kabi9108494Cell saver device insert
Balfour retractorV. MuellerSU3042Used as an abdominal wall retractor
C.A.T.S cell saverFresenius KabiES0019Cell saver device used to wash donor blood
Cardiac defibrillatorZollM SeriesCardiac defibrillator
Castro needle holderV. MuellerCH8589
CG4 iStat cartridgesAbbott03P85-25POC testing
CG8 iStat cartridgesAbbott03P88-25POC testing
DeBakey forcepsV. MuellerCH5902
Electrocautery disposable pencilCovidienE2450H
Gerald forcepsV. MuellerNL1451
Hemotherm 400CE Dual Reservoir Cooler/HeaterCincinnati Sub-Zero86022Heater cooler used to regulate perfusion temperature on the ex vivo perfusion device
iSTAT 1Abbott04P75-03POC testing device
Kocher clampV. MuellerSU2790
Large clip applierSklar50-4300
Large clipsTeleflex4200
Large soft pledgetsCovidien8886867901
Medium clip applierSklar50-4335
Medium clipsTeleflex2200
Metzenbaum scissorV. MuellerCH2006-001
No. 10 scalpel bladeSwann-Mortan301Used for skin incision
No. 11 scalpel bladeKiato Plus18111Used for vascular incision
OCS device with baseTransMedics, Inc.Ex vivo perfusion device
OCS disposableTransMedics, Inc.Ex vivo perfusion device insert with perfusion kits
Pacing cableRemington MedicalFL-601-97
Pediatric cardioplegia catheter (4Fr)Medtronic, Inc10218Used to deliver cardioplegia to the donor aortic root
Pediatric Foley catheterTeleflexRSH170003080Placed pre-op to decompress the recipient's bladder
Potts scissorsV. MuellerCH13038
Pressure bag x2 (1,000 mL)NovaplusV4010HUsed to deliver cardioplegia at a set pressure
Satinsky clampV. MuellerCH7305Vascular clamp used for creating anastomoses between donor heart and recipient vessels
ScissorsFelcoFELCO 200A-50Used to perform sternotomy
Small hard pledgetsCovidien8886867701
Sternal retractorV. MuellerCH6950-007
Temporary cardiac pacing wiresEthicon, Inc.TPW32
Temporary dual chamber pacemakerMedtronic, Inc5388Cardiac pacing device
Tourniquet kitMedtronic, Inc79005Rummel tourniquets
Umbilical tapeCovidien8886861903
Vessel loopsCovidien31145686

References

  1. Virani, S. S., et al. Heart disease and stroke statistics-2021 update: A report from the American Heart Association. Circulation. 143 (8), 254 (2021).
  2. Stehlik, J., Kobashigawa, J., Hunt, S. A., Reichenspurner, H., Kirklin, J. K.

Explore More Articles

PorcineHeterotopicHeart TransplantationCardiac AllograftTherapeuticsPerfusionSternotomyAortic Cross ClampCardioplegia

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved